Johnson & Johnson (JNJ)
265.77
-4.23
(-1.57%)
USD |
NYSE |
Aug 27, 16:00
266.50
+0.73
(+0.27%)
Pre-Market: 07:25
Johnson & Johnson Shareholders Equity (Quarterly) : 84.97B for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 84.97B |
| March 31, 2026 | 81.19B |
| December 31, 2025 | 81.54B |
| September 30, 2025 | 79.28B |
| June 30, 2025 | 78.47B |
| March 31, 2025 | 78.11B |
| December 31, 2024 | 71.49B |
| September 30, 2024 | 70.16B |
| June 30, 2024 | 71.54B |
| March 31, 2024 | 70.02B |
| December 31, 2023 | 68.77B |
| September 30, 2023 | 71.23B |
| June 30, 2023 | 75.15B |
| March 31, 2023 | 70.87B |
| December 31, 2022 | 76.80B |
| September 30, 2022 | 74.60B |
| June 30, 2022 | 76.36B |
| March 31, 2022 | 74.71B |
| December 31, 2021 | 74.02B |
| September 30, 2021 | 70.27B |
| June 30, 2021 | 69.58B |
| March 31, 2021 | 65.83B |
| December 31, 2020 | 63.28B |
| September 30, 2020 | 64.47B |
| June 30, 2020 | 62.98B |
| Date | Value |
|---|---|
| March 31, 2020 | 61.29B |
| December 31, 2019 | 59.47B |
| September 30, 2019 | 58.21B |
| June 30, 2019 | 60.78B |
| March 31, 2019 | 58.96B |
| December 31, 2018 | 59.75B |
| September 30, 2018 | 64.63B |
| June 30, 2018 | 62.89B |
| March 31, 2018 | 63.26B |
| December 31, 2017 | 60.16B |
| September 30, 2017 | 73.98B |
| June 30, 2017 | 71.92B |
| March 31, 2017 | 70.34B |
| December 31, 2016 | 70.42B |
| September 30, 2016 | 72.77B |
| June 30, 2016 | 72.47B |
| March 31, 2016 | 72.65B |
| December 31, 2015 | 71.15B |
| September 30, 2015 | 71.55B |
| June 30, 2015 | 71.13B |
| March 31, 2015 | 67.88B |
| December 31, 2014 | 69.75B |
| September 30, 2014 | 76.59B |
| June 30, 2014 | 78.05B |
| March 31, 2014 | 76.58B |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Eli Lilly & Co. | 33.88B |
| Merck & Co., Inc. | 41.93B |
| Pfizer Inc. | 85.19B |
| Bristol Myers Squibb Co. | 22.32B |
| Liquidia Corp. | 195.11M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 201.06B |
| Total Liabilities (Quarterly) | 116.09B |
| Debt to Equity Ratio | 0.5771 |
| Current Ratio | 1.089 |
| Net Debt Paydown Yield | 0.11% |